Evidence mapPaperPMID 31574903Full record

ReviewNutrients2019

Health-Promoting Properties of Selected Cyclitols for Metabolic Syndrome and Diabetes.

Tomasz Antonowski, Adam Osowski, Lesław Lahuta, Ryszard Górecki, Andrzej Rynkiewicz, Joanna Wojtkiewicz

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. Carob (Nutrients · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Pharmacokinetics ofInternational journal of molecular sciences · 2022
    Article
  18. Review
  19. The Study of Protein-Cyclitol Interactions.International journal of molecular sciences · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tomasz AntonowskiDepartment of Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-082 Olsztyn, Poland. tomasz.antonowski@uwm.edu.pl.
Adam OsowskiDepartment of Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-082 Olsztyn, Poland. adam.osowski@uwm.edu.pl.
Lesław LahutaDepartment of Plant Physiology, Genetics and Biotechnology, University of Warmia and Mazury in Olsztyn, 10-229 Olsztyn, Poland. lahuta@uwm.edu.pl.ORCID 0000-0001-5999-1871
Ryszard GóreckiDepartment of Plant Physiology, Genetics and Biotechnology, University of Warmia and Mazury in Olsztyn, 10-229 Olsztyn, Poland. rigorecki@gmail.com.
Andrzej RynkiewiczDepartment of Plant Physiology, Genetics and Biotechnology, University of Warmia and Mazury in Olsztyn, 10-229 Olsztyn, Poland. andrzej.rynkiewicz@uwm.edu.pl.ORCID 0000-0003-0096-9965
Joanna WojtkiewiczDepartment of Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-082 Olsztyn, Poland. joanna.wojtkiewicz@uwm.edu.pl.ORCID 0000-0003-0856-3644
University of Warmia and Mazury in Olsztyn · PL

Funding

Narodowe Centrum Badań i Rozwoju BIOSTRATEG2/298205/9/NCBR/2016
6 · The paper itself

Abstract

Cyclitols play a particularly important role in cell functioning because they are involved in ion channel physiology, phosphate storage, signal transduction, cell wall formation, membrane biogenesis, osmoregulation and they have antioxidant activity. They are involved in the cell membranes as a phosphatidyl

Indexed as

Dietary SupplementsAnimalsBiomarkersBlood GlucoseCyclitolsDiabetes Mellitus, Type 2HumansHypoglycemic AgentsInositolLipidsMetabolic SyndromeTreatment OutcomeBiomarkersBlood GlucoseCyclitolsHypoglycemic AgentsInositolLipidspinitolD-chiro-inositoldiabetesD-pinitolmetabolic syndromemyo-inositol

Identifiers

PMID31574903
PMCPMC6835238
OpenAlexW2977191228

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.